Integrating EHS Risk Assessments into Change Control and Project Design Integrating EHS Risk Assessments into Change Control and Project Design In the realm of pharmaceutical manufacturing, the integration of Environmental Health and Safety (EHS) risk assessments into change control and project design represents a critical component of compliance and operational excellence. As regulatory requirements from bodies such as the FDA become increasingly stringent, understanding how to navigate the complexities of EHS compliance is essential for professionals in the industry. This article serves as a comprehensive tutorial for pharma professionals on integrating EHS risk assessments into change control processes, ensuring worker…

Ergonomics and Manual Handling Risk Reduction in Packaging and Warehousing Ergonomics and Manual Handling Risk Reduction in Packaging and Warehousing In the rapidly evolving landscape of pharma manufacturing, occupational safety stands paramount. Consequently, the implementation of ergonomics and effective manual handling risk reduction strategies in packaging and warehousing is crucial to ensuring both worker safety and compliance with FDA regulations. This article serves as a comprehensive guide to understanding ergonomics in packaging processes, particularly focusing on hazardous materials and EHS compliance. Understanding the Importance of Ergonomics in Pharma Manufacturing Ergonomics is the scientific study of people at work, particularly how…

Emergency Response Planning and Drills Tailored to Pharma Hazards Introduction to Emergency Response Planning in FDA-Regulated Pharma Manufacturing In the pharmaceutical industry, emergency response planning is a critical component of overall operational safety and compliance. The management of hazardous materials is particularly significant given the potential risks associated with drug manufacturing processes. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the Occupational Safety and Health Administration (OSHA) outline specific requirements that must be adhered to in order to maintain compliance and ensure the safety of personnel and the public alike. This tutorial will guide pharma professionals…

Roadmap to World-Class Safety Performance in FDA-Regulated Manufacturing In the highly regulated environment of FDA-regulated pharmaceutical manufacturing, ensuring safety and compliance is paramount. The integration of effective Environmental, Health, and Safety (EHS) compliance measures, particularly regarding hazardous materials and worker safety, is essential for companies aiming to achieve world-class safety performance. This article provides a comprehensive roadmap that guides Pharma professionals through the intricate landscape of safety performance in FDA-regulated manufacturing settings. Understanding the Regulatory Landscape Before delving into the techniques and best practices for achieving outstanding safety performance, it is crucial to understand the regulatory framework governing hazardous materials…

Aligning EHS Metrics with ESG, Sustainability, and Board-Level Reporting Aligning EHS Metrics with ESG, Sustainability, and Board-Level Reporting In the pharmaceutical industry, the management of environmental, health, and safety (EHS) metrics is becoming increasingly interconnected with environmental, social, and governance (ESG) initiatives. This tutorial provides a step-by-step approach for industry professionals to align EHS compliance with sustainable practices and reporting frameworks, particularly under the oversight of the US FDA and other regulatory bodies in the UK and EU. Understanding EHS Compliance in Pharmaceutical Manufacturing Environmental, Health, and Safety (EHS) compliance is critical in FDA-regulated pharmaceutical manufacturing. It encompasses various practices…

Regulatory Expectations After Serious Incidents or OSHA Inspections Regulatory Expectations After Serious Incidents or OSHA Inspections In the highly regulated environment of pharmaceutical manufacturing, adherence to safety standards and regulatory expectations is paramount. This tutorial outlines the requirements and best practices for managing the aftermath of serious incidents or Occupational Safety and Health Administration (OSHA) inspections, particularly in the context of hazardous materials and EHS compliance. Understanding Regulatory Frameworks for Incident Management Regulatory compliance in the pharmaceutical industry involves various federal and state laws, notably the FDA’s regulations for maintaining safe manufacturing environments, and OSHA regulations that govern workplace safety….

Integrating LCA and ERA into Early Development and CMC Decision-making Integrating Life Cycle Assessment (LCA) and Environmental Risk Assessment (ERA) into Early Development and CMC Decision-making Introduction to Life Cycle Assessment and Environmental Risk Assessment In today’s pharmaceutical industry, integrating sustainability into drug development is no longer optional but rather essential. As regulatory frameworks evolve, incorporating Life Cycle Assessment (LCA) and Environmental Risk Assessment (ERA) into early development processes and Chemistry, Manufacturing, and Controls (CMC) decision-making becomes crucial. This tutorial aims to guide pharmaceutical professionals through the step-by-step processes of implementing LCA and ERA, addressing their importance in drug development,…

Environmental Risk Assessment (ERA) Requirements for APIs in the Environment Environmental Risk Assessment (ERA) Requirements for APIs in the Environment In today’s pharmaceutical landscape, sustainability is becoming a central focus, especially in the context of regulatory compliance and environmental stewardship. This tutorial provides a comprehensive step-by-step guide on the environmental risk assessment (ERA) requirements for active pharmaceutical ingredients (APIs) and their impact on the environment. Understanding the regulations and guidance related to life cycle assessments (LCA) and ERA is essential for pharma professionals, clinical operations, regulatory affairs, and medical affairs experts as they navigate the complex landscape of environmental compliance….

Using LCA to Compare Multi-Use vs Single-Use Equipment Strategies Using LCA to Compare Multi-Use vs Single-Use Equipment Strategies In the evolving landscape of pharmaceuticals and biotechnology, regulatory compliance has become increasingly intertwined with sustainability initiatives. As the industry moves toward greener practices, understanding how to utilize Life Cycle Assessment (LCA) to evaluate multi-use versus single-use equipment strategies is critical for regulatory affairs professionals. This guide aims to explore the relationship between LCA, its application in environmental risk assessments (ERA), and regulatory expectations for product sustainability, particularly for pharmaceuticals and active pharmaceutical ingredients (APIs). Understanding Life Cycle Assessment (LCA) Life Cycle…

Aligning LCA Studies with Net-Zero and Scope 3 Emissions Goals Introduction to Life Cycle Assessment (LCA) Life Cycle Assessment (LCA) is a critical tool in evaluating the environmental impacts associated with all the stages of a product’s life, from cradle to grave. In the pharmaceutical industry, conducting thorough LCAs is increasingly relevant as companies aim to align their operations with sustainability goals, including net-zero and scope 3 emissions targets. This article provides a comprehensive guide to understanding the implications of LCA in regulatory frameworks, particularly in the context of the U.S. Food and Drug Administration (FDA) and environmental risk assessment…